Press Releases
Regulatory
October 28, 2024
Egetis Therapeutics publishes prospectus for admission to trading of shares on Nasdaq Stockholm
Regulatory
October 25, 2024
Bulletin from Egetis Therapeutics’ Extraordinary General Meeting 2024
October 22, 2024
Egetis participates at medical conferences to increase disease awareness about MCT8 deficiency
Upcoming event
November 8, 2024
Latest presentation
June 20, 2024
Latest Report
August 22, 2024
Calendar and upcoming reports
November 8, 2024
Interim Report Q3 2024 (7:00am CET)